Ribavirin Therapy
Ribavirin Therapy is a pharmacological treatment modality within antiviral regimens that specifically employs the nucleoside analog ribavirin to inhibit viral replication, particularly in the management of select forms of acute viral hepatitis, distinguished by its immunomodulatory and direct antiviral mechanisms.
3.7K
Publications
251.7K
Citations
17.4K
Authors
3.8K
Institutions
Publications per year
2017–2026
347
Variants
Ribavirin Treatment
3.7K
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad, Jonathan McCone, Bruce R. Bacon et al. · New England Journal of Medicine · 2011 · 2.5K citations · Full text
1–5 of 3.7K
17.4K
55
h-index
41
h-index
40
h-index
37
h-index
Virginia Commonwealth University Medical Center, United States
51 publications · 25.3K citations
37
h-index
1–5 of 17.4K
3.8K
Inserm
Paris, France
65 h-index
661 publications
64.1K citations

Johns Hopkins University
Baltimore, United States
51 h-index
177 publications
22K citations
Goethe University Frankfurt
Frankfurt am Main, Germany
50 h-index
304 publications
38.2K citations
Gilead Sciences (United States)
Foster City, United States
48 h-index
441 publications
83.5K citations

Sorbonne Université
Paris, France
46 h-index
254 publications
29K citations
Assistance Publique – Hôpitaux de Paris
Paris, France
44 h-index
194 publications
28K citations
Université Paris Cité
Paris, France
44 h-index
166 publications
22.6K citations
National Institutes of Health
Bethesda, United States
42 h-index
299 publications
35.7K citations
1–8 of 3.8K
193 publications · 23.3K citations
87
h-index
260 publications · 14.1K citations
63
h-index
83 publications · 15.5K citations
59
h-index
AAC · 115 publications · 6.4K citations
50
h-index
CID · 74 publications · 6.6K citations
45
h-index
1–5